CRUK Consent Forms – Acalabrutinib, Ibrutinib and Bendamustine-Rituximab
A new consent form for Acalabrutinib has been added for CLL. In addition, Ibrutinib and Bendamustine-Rituximab consent forms have been updated.
They are now available on the CRUK website at: www.cruk.org/sact_consent.
Please share with the members of your organisations and also anyone else who may be interested.
Any questions please let me know.
Alia Nizam, Specialist Oncology Pharmacist. CRUK – Information Lead
Guy’s and St Thomas’ NHS Foundation Trust